Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
95.23
(
-5.88%
)
Bitcoin
76,612.37
(
-0.85%
)
News Focus
News Focus
Post# of 257628
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123010
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 5248

Wednesday, 12/01/2004 1:57:49 AM

Wednesday, December 01, 2004 1:57:49 AM

Post# of 257628
Re: ORPH

>> I think it's an unlikely scenario that someone comes in and develops GHB for a new indication to work around xyrems orphan status. We're talking about a $10M selling drug with optimistic upside of $100M or so (imo). I don't think the return would be there for a second entrant. <<

Fair enough. Have you bought any yet?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today